Skip to Content

Axial SpA – What is New?

Mikkel Østergaard’s presentation at SCR 2023 covers recent developments in the management of axial spondyloarthritis (axSpA), including ASAS-EULAR international recommendations on the use of TNF inhibitors, IL-17 inhibitors, and JAK inhibitors and the impact of NSAIDs on MRI results.

Mikkel Østergaard

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top